Some children get serious bacterial infections that require hospitalization and then a long course of antibiotics to completely treat the infection. Examples of these serious infections include ruptured appendicitis (when the appendix gets inflamed and bursts, releasing bacteria into the abdomen), complicated pneumonia (when an infected pocket of pus forms either in the lung or between the lung and chest wall), and osteomyelitis (an infection of the bone). To extend the duration of antibiotic therapy after discharge from the hospital, doctors will often insert a long catheter called a PICC line in the child’s vein, which can stay in the body for several weeks.
However, PICC lines require a fair amount of maintenance and training of caregivers in their use; require children to restrict their activities; and can lead to serious complications, such as blood stream infections and clots. An alternative to PICC lines is extending the duration of antibiotic therapy with oral antibiotics (pills or syrup) that achieve high levels of medicine in the blood and do not have the extra work, inconvenience, and risks of PICC lines. Unfortunately, there are very few high quality studies that have demonstrated that oral antibiotics are just as good as intravenous antibiotics delivered via a PICC line, and so many doctors still recommend the PICC line treatment option. Also, no studies have been done to compare the impact of these two treatment options on the quality of life of the children and their caregivers.
In this proposal, we outline a series of projects to compare oral antibiotics vs intravenous antibiotics delivered via a PICC line in children who require prolonged (at least one week) home antibiotic therapy after hospitalization for three different serious bacterial infections: ruptured appendicitis, complicated pneumonia, and osteomyelitis. To see whether oral antibiotics are just as good as PICC lines, we will use data collected from more than 15,000 children with one of these three infections who were hospitalized at one of 43 US children’s hospitals during the years 2009 to 2011 and determine whether PICC lines resulted in fewer rehospitalizations for treatment failure than oral therapy.
To see what impact the choice of treatment option has on patient and caregiver quality of life and ability to take the medicine, we will spend 18 months surveying at least 1,000 patients (and their caregivers) who are discharged from four large children’s hospitals with either prolonged oral or intravenous therapy after hospitalization for treatment of ruptured appendicitis, complicated pneumonia, or osteomyelitis. In all our comparisons, we will use special statistics to make sure that we are comparing similar patients in the two treatment groups so that these are fair comparisons.
|Watch this video with audio narration|
Picking the Easier Way to Fight Serious Infections in Children
This Research in Action feature highlights how doctors sometimes prescribe antibiotics delivered intravenously, while new research suggests oral antibiotics can be as effective, with fewer complications.
Continuing Medical Education/Continuing Education Activity
Osteomyelitis in Children
This Continuing Medical Education/Continuing Education activity focuses on early findings of research comparing intravenous (usually via a catheter placed in the arm) and oral antibiotic treatment for osteomyelitis in children after they leave the hospital.